DELETED: Legend Biotech Announces Submission of New Drug Application to Japanese Regulatory Authority for BCMA CAR-T Therapy Cilta-cel for the Treatment of Relapsed or Refractory Multiple Myeloma by Janssen
Rhea-AI Impact
Rhea-AI Sentiment
Rhea-AI Summary
The press release regarding LEGN has been deleted by the news provider, leaving no information available for analysis.
Positive
- None.
Negative
- None.
This story has been deleted by the news provider.
FAQ
What happened to the press release for LEGN?
The press release for LEGN has been deleted by the news provider.
Legend Biotech Corporation American Depositary Shares